The worldwide impact of COVID-19 on cancer care: A meta-analysis of surveys published after the first wave of the pandemic by Serena Di Cosimo, Nicola Susca, Giovanni Apolone, Nicola Silvestris, Vito Racanelli

Get full text

Treatment of oligometastatic breast cancer: The role of patient selection by Riccardo Ray Colciago, Maria Carmen De Santis, Carlotta Giandini, Maria Grazia Carnevale, Serena Di Cosimo

Get full text

Did Michelangelo paint a young adult woman with breast cancer in “The Flood” (Sistine Chapel, Rome)? by Andreas G. Nerlich, Johann C. Dewaal, Antonio Perciaccante, Serena Di Cosimo, Laura Cortesi, Judith Wimmer, Simon T. Donell, Raffaella Bianucci

Get full text

Direct and indirect effects of COVID-19 on short-term mortality of breast cancer patients by Serena Di Cosimo, Silva Ljevar, Annalisa Trama, Alice Bernasconi, Paolo Lasalvia, Maria Carmen De Santis, Vera Cappelletti, Rosalba Miceli, Giovanni Apolone

Get full text

Nobody dares stopping clinical research, not even COVID-19 by Andrea Malfettone, Serena Di Cosimo, José Manuel Pérez-García, Alicia García, Miguel Sampayo-Cordero, Leonardo Mina, Carolina Herrero, Antonio Llombart-Cussac, Javier Cortés

Get full text

Low-pass whole genome sequencing of circulating tumor cells to evaluate chromosomal instability in triple-negative breast cancer by Serena Di Cosimo, Marco Silvestri, Cinzia De Marco, Alessia Calzoni, Maria Carmen De Santis, Maria Grazia Carnevale, Carolina Reduzzi, Massimo Cristofanilli, Vera Cappelletti

Get full text

Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma by Marco Silvestri, Trung Nghia Vu, Federico Nichetti, Monica Niger, Serena Di Cosimo, Filippo De Braud, Giancarlo Pruneri, Yudi Pawitan, Stefano Calza, Vera Cappelletti

Get full text

A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy by Alberto Zambelli, Marina Cazzaniga, Nicla La Verde, Elisabetta Munzone, Ippazio Cosimo Antonazzo, Lorenzo Giovanni Mantovani, Serena Di Cosimo, Anna Mancuso, Daniele Generali, Paolo Angelo Cortesi

Get full text

ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer by Fatima Cardoso, Dario Trapani, Carmen Criscitiello, Giuseppe Curigliano, Evandro de Azambuja, Sibylle Loibl, Suzette Delaloge, Elzbieta Senkus, Philip Poortman, Michael Gnant, Serena Di Cosimo, Javier Cortes, Shani Paluch-Shimon

Get full text

Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial by Mattia Rediti, David Venet, Andrea Joaquin Garcia, Marion Maetens, Delphine Vincent, Samira Majjaj, Sarra El-Abed, Serena Di Cosimo, Takayuki Ueno, Miguel Izquierdo, Martine Piccart, Lajos Pusztai, Sherene Loi, Roberto Salgado, Giuseppe Viale, Françoise Rothé, Christos Sotiriou

Get full text

A gene expression-based classifier for HER2-low breast cancer by Serena Di Cosimo, Sara Pizzamiglio, Chiara Maura Ciniselli, Valeria Duroni, Vera Cappelletti, Loris De Cecco, Cinzia De Marco, Marco Silvestri, Maria Carmen De Santis, Andrea Vingiani, Biagio Paolini, Rosaria Orlandi, Marilena Valeria Iorio, Giancarlo Pruneri, Paolo Verderio

Get full text

Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial by Tomás Pascual, Mafalda Oliveira, Patricia Villagrasa, Vanesa Ortega, Laia Paré, Begoña Bermejo, Serafín Morales, Kepa Amillano, Rafael López, Patricia Galván, Jordi Canes, Fernando Salvador, Paolo Nuciforo, Isabel T. Rubio, Antonio Llombart-Cussac, Serena Di Cosimo, José Baselga, Nadia Harbeck, Aleix Prat, Javier Cortés

Get full text

End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO by Serena Di Cosimo, Chiara M. Ciniselli, Sara Pizzamiglio, Vera Cappelletti, Marco Silvestri, Sarra El-Abed, Miguel Izquierdo, Mohammed Bajji, Paolo Nuciforo, Jens Huober, Jens Huober, David Cameron, Stephen Chia, Henry L. Gomez, Henry L. Gomez, Marilena V. Iorio, Andrea Vingiani, Giancarlo Pruneri, Paolo Verderio

Get full text

Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study. by Serena Di Cosimo, Nicla La Verde, Anna Moretti, Marina Elena Cazzaniga, Daniele Generali, Giulia Valeria Bianchi, Luigi Mariani, Valter Torri, Flavio Crippa, Biagio Paolini, Gianfranco Scaperrotta, Maria Carmen De Santis, Massimo Di Nicola, Giovanni Apolone, Alessandro Gulino, Claudio Tripodo, Mario Paolo Colombo, Secondo Folli, Filippo de Braud

Get full text

What if the future of HER2‐positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study by Sara Pizzamiglio, Giulia Cosentino, Chiara M. Ciniselli, Loris De Cecco, Alessandra Cataldo, Ilaria Plantamura, Tiziana Triulzi, Sarra El‐abed, Yingbo Wang, Mohammed Bajji, Paolo Nuciforo, Jens Huober, Susan L. Ellard, David L. Rimm, Andrea Gombos, Maria Grazia Daidone, Paolo Verderio, Elda Tagliabue, Serena Di Cosimo, Marilena V. Iorio

Get full text

The TRAR gene classifier to predict response to neoadjuvant therapy in HER2‐positive and ER‐positive breast cancer patients: an explorative analysis from the NeoSphere trial by Tiziana Triulzi, Giampaolo Bianchini, Serena Di Cosimo, Tadeusz Pienkowski, Young‐Hyuck Im, Giulia Valeria Bianchi, Barbara Galbardi, Matteo Dugo, Loris De Cecco, Ling‐Ming Tseng, Mei‐Ching Liu, Begoña Bermejo, Vladimir Semiglazov, Giulia Viale, Juan de laHaba‐Rodriguez, Do‐Youn Oh, Brigitte Poirier, Pinuccia Valagussa, Luca Gianni, Elda Tagliabue

Get full text

COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial by Chiara Agrati, Serena Di Cosimo, Daniela Fenoglio, Daniela Fenoglio, Giovanni Apolone, Fabio Ciceri, Gennaro Ciliberto, Fausto Baldanti, Massimo Costantini, Diana Giannarelli, Giuseppe Ippolito, Franco Locatelli, Alberto Mantovani, Alberto Mantovani, Alberto Mantovani, Aldo Morrone, Fabrizio Tagliavini, Antonio Uccelli, Antonio Uccelli, Pier Luigi Zinzani, Pier Luigi Zinzani, Nicola Silvestris, Nicola Silvestris, Maria Rescigno, Maria Rescigno

Get full text

Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer by Serena Di Cosimo, José Manuel Pérez-García, Meritxell Bellet, Florence Dalenc, Miguel J. Gil Gil, Manuel Ruiz-Borrego, Joaquín Gavilá, Elena Aguirre, Peter Schmid, Frederik Marmé, Joseph Gligorov, Andreas Schneeweiss, Joan Albanell, Pilar Zamora, Duncan Wheatley, Eduardo Martínez de Dueñas, Kepa Amillano, Eileen Shimizu, Miguel Sampayo-Cordero, Javier Cortés, Antonio Llombart-Cussac

Get full text

Safety of third dose of COVID-19 vaccination in frail patients: Results from the prospective Italian VAX4FRAIL study by Serena Di Cosimo, Maria Teresa Lupo-Stanghellini, Massimo Costantini, Renato Mantegazza, Fabio Ciceri, Fabio Ciceri, Carlo Salvarani, Carlo Salvarani, Pier Luigi Zinzani, Pier Luigi Zinzani, Alberto Mantovani, Alberto Mantovani, Alberto Mantovani, Gennaro Ciliberto, Antonio Uccelli, Antonio Uccelli, Fausto Baldanti, Fausto Baldanti, Giovanni Apolone, Sabina Delcuratolo, Aldo Morrone, Franco Locatelli, Franco Locatelli, Chiara Agrati, Nicola Silvestris

Get full text

Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials by Mattia Rediti, Aranzazu Fernandez-Martinez, David Venet, Françoise Rothé, Katherine A. Hoadley, Joel S. Parker, Baljit Singh, Jordan D. Campbell, Karla V. Ballman, David W. Hillman, Eric P. Winer, Sarra El-Abed, Martine Piccart, Serena Di Cosimo, William Fraser Symmans, Ian E. Krop, Roberto Salgado, Sherene Loi, Lajos Pusztai, Charles M. Perou, Lisa A. Carey, Christos Sotiriou

Get full text